雪佛龙
CVX
克罗格
KR
西方石油
OXY
德维特
DVA
可口可乐
KO
美股市场个股详情
EYPT EyePoint Pharmaceuticals
- 8.215
- -0.895-9.82%
交易中 01/10 15:23 (美东)
5.61亿总市值-4.13市盈率TTM
9.010最高价8.160最低价52.63万股成交量9.000今开9.110昨收449.03万成交额1.12%换手率亏损市盈率(静)6825.10万总股本30.99052周最高2.56市净率3.85亿流通值6.90052周最低--股息TTM4681.61万流通股72.200历史最高--股息率TTM9.33%振幅2.190历史最低8.532平均价1股每手
EyePoint Pharmaceuticals所有资讯
EyePoint Pharmaceuticals | 3：首次持股声明-董事 Sanders Reginald J.
EyePoint Pharmaceuticals | 4：持股变动声明-董事 Sanders Reginald J.
EyePoint Pharmaceuticals | 4：持股变动声明-董事 Zaderej Karen L.
EyePoint Pharmaceuticals | 4：持股变动声明-董事 Hassan Fred
EyePoint Pharmaceuticals | 4：持股变动声明-董事 ANDO GORAN
EyePoint Pharmaceuticals | 4：持股变动声明-董事 Duty Stuart
EyePoint Pharmaceuticals | 4：持股变动声明-董事 DICICCO WENDY F
EyePoint Pharmaceuticals | 4：持股变动声明-高管 Ribeiro Ramiro
EyePoint Pharmaceuticals | 4：持股变动声明-高管 Elston George
EyePoint Pharmaceuticals | 4：持股变动声明-董事 Lurker Nancy
EyePoint Pharmaceuticals | 4：持股变动声明-董事 Landis John B.
EyePoint Pharmaceuticals | 4：持股变动声明-高管 Duker Jay S.
EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(12.20%),Bihua Chen(12.20%)
EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(4.7%)
EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(5.69%)
EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Adage Capital Management, L.P.(7.08%),Robert Atchinson(7.08%)等
EyePoint Pharmaceuticals | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(7.8%)
EyePoint Pharmaceuticals | SC 13G：超过5%持股股东披露文件-TCG Crossover GP II, LLC(5.2%),TCG Crossover Fund II, L.P.(5.2%)等
EyePoint Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Federated Hermes, Inc.(5.44%),Voting Shares Irrevocable Trust(5.44%)等
EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(5.69%)